DUBLIN--(BUSINESS WIRE)--The "Parkinson's Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) - Global Forecast to 2022" report has been added to Research and Markets' offering.
The Parkinson's disease treatment market is expected to grow from USD 4.24 billion in 2017 to USD 5,694.1 million in 2022 to grow at a CAGR of 6.1%. Factors such as the increasing aging population worldwide and government funding for research on Parkinson's disease are driving this market. However, the availability of alternative treatments is expected to restrain this market.
On the basis of drug class, the Parkinson's disease treatment market is classified into carbidopa/levodopa, dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to register the highest growth rate during the forecast period. The growth of this market segment is mainly driven by its potency and wide adoption in the treatment of Parkinson's disease.
By distribution channel type, the Parkinson's disease treatment market is segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. The online pharmacies segment is expected to register highest CAGR during the forecast period. Advantages such as 24/7 ordering, home delivery, and discounts on medicines are the driving factors for this segment.
Companies Mentioned
- Abbvie
- Acadia
- Boehringer Ingelheim
- GSK
- Impax
- Lundbeck
- Merck
- Novartis
- Sun Pharma
- Teva
- UCB
- Valeant Pharmaceuticals
- Wockhardt
Key Topics Covered:
1 Parkinson's Disease Treatment Market: Introduction
2 Parkinson's Disease Treatment Market: Research Methodology
3 Parkinson's Disease Treatment Market: Executive Summary
4 Parkinson's Disease Treatment Market: Premium Insights
5 Parkinson's Disease Treatment Market: Overview
6 Parkinson's Disease Treatment Market, By Drug Class
7 Parkinson's Disease Treatment Market, By Distribution Channel
8 Parkinson's Disease Treatment Market, By Patient Care Setting
9 Parkinson's Disease Treatment Market, By Region
10 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/cvmltf/parkinsons
